GO/Pathway/Gene Set/Gene ID	GO/Pathway/Gene Set/Gene Name	All Genes (Expression Data)	All Genes (Platform)	Input Genes	Genes with BMD <= Highest Dose	Genes with BMD p-Value >= 	Genes with BMD/BMDL <= 	Genes with BMDU/BMD <= 	Genes with BMDU/BMDL <= 	Genes with BMD <= N-Fold Lowest Positive Dose 	Genes That Passed All Filters	Fisher's A Parameter	Fisher's B Parameter	Fisher's C Parameter	Fisher's D Parameter	Fisher's Exact Left P-Value	Fisher's Exact Right P-Value	Fisher's Exact Two Tail	Percentage	Entrez Gene IDs	Gene Symbols	Probe IDs	Genes with Conflicting Probesets	BMD Mean	BMD Median	BMD Minimum	BMD Standard Deviation	BMD wMean	BMD wSD	BMDL Mean	BMDL Median	BMDL Minimum	BMDL Standard Deviation	BMDL wMean	BMDL wSD	BMDU Mean	BMDU Median	BMDU Minimum	BMDU Standard Deviation	BMDU wMean	BMDU wSD	5th Percentile Index	BMD at 5th Percentile of Total Genes	10th Percentile Index	BMD at 10th Percentile of Total Genes	BMD List	BMDL List	BMDU List	Probes with Adverse Direction Up	Probes with Adverse Direction Down	Genes with Adverse Direction Up	Genes Up List	Genes Up Probes List	Genes Up BMD Mean	Genes Up BMD Median	Genes Up SD	Genes Up BMDL Mean	Genes Up BMDL Median	Genes Up BMDL SD	Genes Up BMDU Mean	Genes Up BMDU Median	Genes Up BMDU SD	BMD list (up)	BMDL List (up)	BMDU List (up)	Genes with Adverse Direction Down	Genes Down List	Genes Down Probes List	Genes Down BMD Mean	Genes Down BMD Median	Genes Down SD	Genes Down BMDL Mean	Genes Down BMDL Median	Genes Down BMDL SD	Genes Down BMDU Mean	Genes Down BMDU Median	Genes Down BMDU SD	BMD list (down)	BMDL List (down)	BMDU List (down)	Genes with Adverse Conflict Count	Genes Conflict List	Genes Conflict Probes List	BMD list (Conflict)	BMDL list (Conflict)	BMDU list (Conflict)	Model Counts	Mean Fold Change	Total Fold Change	Min Fold Change	Max Fold Change	Standard Deviation Fold Change	Median Fold Change	Lower bound of the 95% confidence interval -  BMD	Upper bound of the 95% confidence interval -  BMD	Lower bound of the 95% confidence interval -  BMDL	Upper bound of the 95% confidence interval -  BMDL	Lower bound of the 95% confidence interval -  BMDU	Upper bound of the 95% confidence interval -  BMDU	Overall Direction	Percent Genes With Overall Direction Up	Percent Genes With Overall Direction Down	Percent Genes With Overall Direction Conflict
R-DRE-109582	Hemostasis	288	307	2	2	0	2	2	2	2	0	0	9	307	4576	0.55778	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-168249	Innate Immune System	474	502	2	2	2	1	2	1	2	1	1	8	501	4382	0.76587	0.62292	1.0	0.2	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-168256	Immune System	767	839	4	3	2	3	3	2	4	1	1	8	838	4045	0.52643	0.81637	1.0	0.12	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-6798695	Neutrophil degranulation	278	300	2	2	2	1	2	1	2	1	1	8	299	4584	0.89858	0.4345	0.4345	0.33	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-1430728	Metabolism	1000	1029	3	3	2	2	3	2	3	1	1	8	1028	3855	0.40539	0.88085	0.69476	0.097	402826	amdhd1	ENSDARG00000007366		1.03994	1.03994	1.03994		1.03994		0.617213	0.617213	0.617213		0.617213		2.4619	2.4619	2.4619		2.4619						1.03994	0.617213	2.4619	0	1	0															1	402826	ENSDARG00000007366	1.03994	1.03994		0.617213	0.617213		2.4619	2.4619		1.03994	0.617213	2.4619	0						Exp 2,1(1)	1.631037950515747	1.631037950515747	1.631037950515747	1.631037950515747	0.0	1.631037950515747	1.03994	1.03994	0.617213	0.617213	2.4619	2.4619	DOWN	0.0	1.0	0.0	
R-DRE-1500931	Cell-Cell communication	37	39	1	1	0	1	1	1	1	0	0	9	39	4844	0.93044	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-392499	Metabolism of proteins	937	976	2	1	1	2	1	1	2	1	1	8	975	3908	0.43751	0.86529	1.0	0.1	553692	dph3	ENSDARG00000043360		1.17298	1.17298	1.17298		1.1729799999999997		0.769009	0.769009	0.769009		0.7690090000000002		2.42018	2.42018	2.42018		2.42018						1.17298	0.769009	2.42018	1	0	1	553692	ENSDARG00000043360	1.17298	1.17298		0.769009	0.769009		2.42018	2.42018		1.17298	0.769009	2.42018	0															0						Linear,1(1)	1.7452269792556763	1.7452269792556763	1.7452269792556763	1.7452269792556763	0.0	1.7452269792556763	1.17298	1.17298	0.769009	0.769009	2.42018	2.42018	UP	1.0	0.0	0.0	
R-DRE-597592	Post-translational protein modification	723	751	2	1	1	2	1	1	2	1	1	8	750	4133	0.58726	0.77716	1.0	0.13	553692	dph3	ENSDARG00000043360		1.17298	1.17298	1.17298		1.1729799999999997		0.769009	0.769009	0.769009		0.7690090000000002		2.42018	2.42018	2.42018		2.42018						1.17298	0.769009	2.42018	1	0	1	553692	ENSDARG00000043360	1.17298	1.17298		0.769009	0.769009		2.42018	2.42018		1.17298	0.769009	2.42018	0															0						Linear,1(1)	1.7452269792556763	1.7452269792556763	1.7452269792556763	1.7452269792556763	0.0	1.7452269792556763	1.17298	1.17298	0.769009	0.769009	2.42018	2.42018	UP	1.0	0.0	0.0	
R-DRE-1257604	PIP3 activates AKT signaling	150	159	2	1	1	2	1	1	2	1	1	8	158	4725	0.96748	0.25742	0.25742	0.63	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-1280218	Adaptive Immune System	327	364	3	2	1	3	2	2	3	1	1	8	363	4520	0.85952	0.50166	0.50166	0.27	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-162582	Signal Transduction	1243	1352	14	8	6	12	7	6	14	4	4	5	1348	3535	0.92774	0.21812	0.27238	0.3	556770;503868;368245;322473	gpr183a;vipr1b;fgf19;lpar5a	ENSDARG00000010317;ENSDARG00000059058;ENSDARG00000098663;ENSDARG00000010384		0.779770981875	0.8115935	8.69275E-5	0.7024586016101313	0.955414833366293	0.6306281450404373	0.431336964825	0.46270599999999995	5.18593E-5	0.4202524189331985	0.5475749375942658	0.3916928595410144	2.6642424095	2.69096	1.79638E-4	2.153871629822009	2.988662962758167	1.8712672948678326					0.388687;1.49581;8.69275E-5;1.2345	0.141743;0.783669;5.18593E-5;0.799884	2.73252;5.27487;1.79638E-4;2.6494	1	3	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	3	556770;503868;322473	ENSDARG00000010317;ENSDARG00000059058;ENSDARG00000010384	1.0396656666666668	1.2345	0.5787060111717635	0.5750986666666666	0.783669	0.3753845787060696	3.5522633333333338	2.73252	1.4923999228200633	0.388687;1.49581;1.2345	0.141743;0.783669;0.799884	2.73252;5.27487;2.6494	0						Exp 2,1(0.25);Exp 4,1(0.25);Linear,1(0.25);Poly 2,1(0.25)	1.7938136641541271	7.215246677398682	1.5919537544250488	2.1081173419952393	0.22329195497739976	1.7575877904891968	0.09136155229707132	1.4681804114529289	0.019489594270465427	0.8431843353795345	0.5534482122744309	4.775036606725569	DOWN	0.25	0.75	0.0	
R-DRE-1640170	Cell Cycle	372	392	7	3	1	6	3	2	7	0	0	9	392	4491	0.47125	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-199418	Negative regulation of the PI3K/AKT network	65	69	2	1	1	2	1	1	2	1	1	8	68	4815	0.99338	0.1201	0.1201	1.45	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-199991	Membrane Trafficking	312	314	3	3	1	2	2	2	3	0	0	9	314	4569	0.55015	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-212436	Generic Transcription Pathway	459	488	4	3	1	3	3	2	4	0	0	9	488	4395	0.38805	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-3700989	Transcriptional Regulation by TP53	205	210	2	2	1	1	2	1	2	0	0	9	210	4673	0.67354	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-372790	Signaling by GPCR	300	374	7	4	4	6	3	3	7	3	3	6	371	4512	0.99689	0.026307	0.026307	0.8	556770;503868;322473	gpr183a;vipr1b;lpar5a	ENSDARG00000010317;ENSDARG00000059058;ENSDARG00000010384		1.0396656666666668	1.2345	0.388687	0.5787060111717635	1.1053322714692715	0.518719580834392	0.5750986666666666	0.783669	0.141743	0.3753845787060696	0.6334964904936333	0.34358012774530716	3.5522633333333338	2.73252	2.6494	1.4923999228200633	3.4576388621431478	1.457855125073046					0.388687;1.49581;1.2345	0.141743;0.783669;0.799884	2.73252;5.27487;2.6494	0	3	0															3	556770;503868;322473	ENSDARG00000010317;ENSDARG00000059058;ENSDARG00000010384	1.0396656666666668	1.2345	0.5787060111717635	0.5750986666666666	0.783669	0.3753845787060696	3.5522633333333338	2.73252	1.4923999228200633	0.388687;1.49581;1.2345	0.141743;0.783669;0.799884	2.73252;5.27487;2.6494	0						Exp 2,1(0.34);Linear,1(0.34);Poly 2,1(0.34)	1.6998274706722754	5.107129335403442	1.5919537544250488	1.8201133012771606	0.11425549206462217	1.695062279701233	0.38479816685658896	1.6945331664767442	0.15031102703812294	0.9998863062952104	1.8634538388630018	5.241072827803666	DOWN	0.0	1.0	0.0	
R-DRE-388396	GPCR downstream signalling	287	360	7	4	4	6	3	3	7	3	3	6	357	4526	0.9973	0.02377	0.02377	0.83	556770;503868;322473	gpr183a;vipr1b;lpar5a	ENSDARG00000010317;ENSDARG00000059058;ENSDARG00000010384		1.0396656666666668	1.2345	0.388687	0.5787060111717635	1.1053322714692715	0.518719580834392	0.5750986666666666	0.783669	0.141743	0.3753845787060696	0.6334964904936333	0.34358012774530716	3.5522633333333338	2.73252	2.6494	1.4923999228200633	3.4576388621431478	1.457855125073046					0.388687;1.49581;1.2345	0.141743;0.783669;0.799884	2.73252;5.27487;2.6494	0	3	0															3	556770;503868;322473	ENSDARG00000010317;ENSDARG00000059058;ENSDARG00000010384	1.0396656666666668	1.2345	0.5787060111717635	0.5750986666666666	0.783669	0.3753845787060696	3.5522633333333338	2.73252	1.4923999228200633	0.388687;1.49581;1.2345	0.141743;0.783669;0.799884	2.73252;5.27487;2.6494	0						Exp 2,1(0.34);Linear,1(0.34);Poly 2,1(0.34)	1.6998274706722754	5.107129335403442	1.5919537544250488	1.8201133012771606	0.11425549206462217	1.695062279701233	0.38479816685658896	1.6945331664767442	0.15031102703812294	0.9998863062952104	1.8634538388630018	5.241072827803666	DOWN	0.0	1.0	0.0	
R-DRE-388841	Costimulation by the CD28 family	33	34	1	0	0	1	0	0	1	0	0	9	34	4849	0.93911	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-389356	CD28 co-stimulation	24	24	1	0	0	1	0	0	1	0	0	9	24	4859	0.95667	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-389357	CD28 dependent PI3K/Akt signaling	18	18	1	0	0	1	0	0	1	0	0	9	18	4865	0.96734	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-389513	CTLA4 inhibitory signaling	16	16	1	0	0	1	0	0	1	0	0	9	16	4867	0.97092	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5633007	Regulation of TP53 Activity	102	107	1	1	1	0	1	0	1	0	0	9	107	4776	0.81938	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5653656	Vesicle-mediated transport	331	337	4	4	2	3	3	3	4	1	1	8	336	4547	0.87645	0.47425	0.47425	0.3	327588	hpxa	ENSDARG00000012609		1.22493	1.22493	1.22493		1.22493		0.795138	0.795138	0.795138		0.795138		2.61243	2.61243	2.61243		2.6124299999999994						1.22493	0.795138	2.61243	1	0	1	327588	ENSDARG00000012609	1.22493	1.22493		0.795138	0.795138		2.61243	2.61243		1.22493	0.795138	2.61243	0															0						Linear,1(1)	2.2946460247039795	2.2946460247039795	2.2946460247039795	2.2946460247039795	0.0	2.2946460247039795	1.22493	1.22493	0.795138	0.795138	2.61243	2.61243	UP	1.0	0.0	0.0	
R-DRE-69278	Cell Cycle, Mitotic	312	331	5	2	0	5	2	2	5	0	0	9	331	4552	0.53202	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73857	RNA Polymerase II Transcription	495	524	4	3	1	3	3	2	4	0	0	9	524	4359	0.3604	1.0	0.61018	0.0																														0	0	0															0															0																							
R-DRE-74160	Gene expression (Transcription)	557	586	4	3	1	3	3	2	4	0	0	9	586	4297	0.31685	1.0	0.6112	0.0																														0	0	0															0															0																							
R-DRE-9006925	Intracellular signaling by second messengers	166	175	2	1	1	2	1	1	2	1	1	8	174	4709	0.96118	0.27973	0.27973	0.57	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-9006934	Signaling by Receptor Tyrosine Kinases	250	254	2	2	2	1	2	1	2	1	1	8	253	4630	0.92405	0.38138	0.38138	0.39	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-373076	Class A/1 (Rhodopsin-like receptors)	149	219	4	3	3	3	2	2	4	2	2	7	217	4666	0.99392	0.058352	0.058352	0.91	556770;322473	gpr183a;lpar5a	ENSDARG00000010317;ENSDARG00000010384		0.8115935	0.8115935	0.388687	0.5980801079157373	0.9379244332114968	0.570772113993251	0.4708135	0.4708135	0.141743	0.4653759640768957	0.5691136759428477	0.444127165077425	2.69096	2.69096	2.6494	0.05877471565221903	2.6785451669712574	0.05609109592203934					0.388687;1.2345	0.141743;0.799884	2.73252;2.6494	0	2	0															2	556770;322473	ENSDARG00000010317;ENSDARG00000010384	0.8115935	0.8115935	0.5980801079157373	0.4708135	0.4708135	0.4653759640768957	2.69096	2.69096	0.05877471565221903	0.388687;1.2345	0.141743;0.799884	2.73252;2.6494	0						Linear,1(0.5);Poly 2,1(0.5)	1.7564752778725354	3.5151755809783936	1.695062279701233	1.8201133012771606	0.08842442535064376	1.7575877904891968	-0.017303239999999942	1.6404902399999999	-0.1741646799999999	1.11579168	2.6095023999999998	2.7724176000000003	DOWN	0.0	1.0	0.0	
R-DRE-375276	Peptide ligand-binding receptors	88	108	1	0	0	1	0	0	1	0	0	9	108	4775	0.81784	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-416476	G alpha (q) signalling events	112	125	2	1	1	2	1	1	2	1	1	8	124	4759	0.97927	0.20796	0.20796	0.8	322473	lpar5a	ENSDARG00000010384		1.2345	1.2345	1.2345		1.2345		0.799884	0.799884	0.799884		0.799884		2.6494	2.6494	2.6494		2.6494						1.2345	0.799884	2.6494	0	1	0															1	322473	ENSDARG00000010384	1.2345	1.2345		0.799884	0.799884		2.6494	2.6494		1.2345	0.799884	2.6494	0						Linear,1(1)	1.8201133012771606	1.8201133012771606	1.8201133012771606	1.8201133012771606	0.0	1.8201133012771606	1.2345	1.2345	0.799884	0.799884	2.6494	2.6494	DOWN	0.0	1.0	0.0	
R-DRE-418594	G alpha (i) signalling events	144	166	3	3	3	2	2	2	3	2	2	7	164	4719	0.99723	0.035224	0.035224	1.2	556770;322473	gpr183a;lpar5a	ENSDARG00000010317;ENSDARG00000010384		0.8115935	0.8115935	0.388687	0.5980801079157373	0.9379244332114968	0.570772113993251	0.4708135	0.4708135	0.141743	0.4653759640768957	0.5691136759428477	0.444127165077425	2.69096	2.69096	2.6494	0.05877471565221903	2.6785451669712574	0.05609109592203934					0.388687;1.2345	0.141743;0.799884	2.73252;2.6494	0	2	0															2	556770;322473	ENSDARG00000010317;ENSDARG00000010384	0.8115935	0.8115935	0.5980801079157373	0.4708135	0.4708135	0.4653759640768957	2.69096	2.69096	0.05877471565221903	0.388687;1.2345	0.141743;0.799884	2.73252;2.6494	0						Linear,1(0.5);Poly 2,1(0.5)	1.7564752778725354	3.5151755809783936	1.695062279701233	1.8201133012771606	0.08842442535064376	1.7575877904891968	-0.017303239999999942	1.6404902399999999	-0.1741646799999999	1.11579168	2.6095023999999998	2.7724176000000003	DOWN	0.0	1.0	0.0	
R-DRE-500792	GPCR ligand binding	192	264	6	4	4	5	3	3	6	3	3	6	261	4622	0.99916	0.010237	0.010237	1.14	556770;503868;322473	gpr183a;vipr1b;lpar5a	ENSDARG00000010317;ENSDARG00000059058;ENSDARG00000010384		1.0396656666666668	1.2345	0.388687	0.5787060111717635	1.1053322714692715	0.518719580834392	0.5750986666666666	0.783669	0.141743	0.3753845787060696	0.6334964904936333	0.34358012774530716	3.5522633333333338	2.73252	2.6494	1.4923999228200633	3.4576388621431478	1.457855125073046					0.388687;1.49581;1.2345	0.141743;0.783669;0.799884	2.73252;5.27487;2.6494	0	3	0															3	556770;503868;322473	ENSDARG00000010317;ENSDARG00000059058;ENSDARG00000010384	1.0396656666666668	1.2345	0.5787060111717635	0.5750986666666666	0.783669	0.3753845787060696	3.5522633333333338	2.73252	1.4923999228200633	0.388687;1.49581;1.2345	0.141743;0.783669;0.799884	2.73252;5.27487;2.6494	0						Exp 2,1(0.34);Linear,1(0.34);Poly 2,1(0.34)	1.6998274706722754	5.107129335403442	1.5919537544250488	1.8201133012771606	0.11425549206462217	1.695062279701233	0.38479816685658896	1.6945331664767442	0.15031102703812294	0.9998863062952104	1.8634538388630018	5.241072827803666	DOWN	0.0	1.0	0.0	
R-DRE-983169	Class I MHC mediated antigen processing & presentation	219	231	2	2	1	2	2	2	2	1	1	8	230	4653	0.93581	0.35319	0.35319	0.43	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-1236974	ER-Phagosome pathway	19	21	1	1	1	1	1	1	1	1	1	8	20	4863	0.99938	0.038008	0.038008	4.76	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-1236975	Antigen processing-Cross presentation	60	65	2	2	1	2	2	2	2	1	1	8	64	4819	0.99411	0.11351	0.11351	1.54	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-1236977	Endosomal/Vacuolar pathway	10	12	1	1	1	1	1	1	1	1	1	8	11	4872	0.9998	0.021879	0.021879	8.33	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346		0.0	1.26442			1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-382551	Transport of small molecules	355	372	2	2	2	2	2	2	2	2	2	7	370	4513	0.97406	0.14561	0.14561	0.54	566555;108181672	abcc6a;cr339041.1	ENSDARG00000016750;ENSDARG00000051710		1.5346350000000002	1.5346350000000002	1.26442	0.3821417177566449	1.439570985771413	0.35771211727797575	0.9770115	0.9770115	0.906053	0.10035047306565119	0.9520476754394124	0.09393525627322298	4.29563	4.29563	2.21346	2.944633053166387	3.563104276015996	2.756388206549181					1.80485;1.26442	1.04797;0.906053	6.3778;2.21346	2	0	2	566555;108181672	ENSDARG00000016750;ENSDARG00000051710	1.5346350000000002	1.5346350000000002	0.3821417177566449	0.9770115	0.9770115	0.10035047306565119	4.29563	4.29563	2.944633053166387	1.80485;1.26442	1.04797;0.906053	6.3778;2.21346	0															0						Exp 2,1(0.5);Linear,1(0.5)	1.5250034423043408	3.050326943397522	1.5030701160430908	1.5472568273544312	0.031244723206581074	1.525163471698761	1.0050136000000003	2.0642564	0.83793284	1.1160901600000002	0.21457680000000057	8.376683199999999	UP	1.0	0.0	0.0	
R-DRE-917937	Iron uptake and transport	43	45	1	1	1	1	1	1	1	1	1	8	44	4839	0.99714	0.079869	0.079869	2.22	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-917977	Transferrin endocytosis and recycling	25	27	1	1	1	1	1	1	1	1	1	8	26	4857	0.99897	0.048629	0.048629	3.7	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	21	23	1	1	1	1	1	1	1	1	1	8	22	4861	0.99925	0.04156	0.04156	4.35	108181672	cr339041.1	ENSDARG00000051710		1.26442	1.26442	1.26442		1.26442		0.906053	0.906053	0.906053		0.9060530000000001		2.21346	2.21346	2.21346		2.21346						1.26442	0.906053	2.21346	1	0	1	108181672	ENSDARG00000051710	1.26442	1.26442		0.906053	0.906053		2.21346	2.21346		1.26442	0.906053	2.21346	0															0						Exp 2,1(1)	1.5472568273544312	1.5472568273544312	1.5472568273544312	1.5472568273544312	0.0	1.5472568273544312	1.26442	1.26442	0.906053	0.906053	2.21346	2.21346	UP	1.0	0.0	0.0	
R-DRE-109704	PI3K Cascade	28	31	1	1	1	1	1	1	1	1	1	8	30	4853	0.99864	0.055652	0.055652	3.23	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-112399	IRS-mediated signalling	28	31	1	1	1	1	1	1	1	1	1	8	30	4853	0.99864	0.055652	0.055652	3.23	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-1307965	betaKlotho-mediated ligand binding	3	3	1	1	1	1	1	1	1	1	1	8	2	4881	0.99999	0.0055102	0.0055102	33.33	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4		0.0	8.69275E-5	0.0	8.69275E-5	8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-190236	Signaling by FGFR	62	64	1	1	1	1	1	1	1	1	1	8	63	4820	0.99428	0.11185	0.11185	1.56	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-190322	FGFR4 ligand binding and activation	9	10	1	1	1	1	1	1	1	1	1	8	9	4874	0.99987	0.018262	0.018262	10.0	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4		0.0	8.69275E-5	0.0	8.69275E-5	8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	33	36	1	1	1	1	1	1	1	1	1	8	35	4848	0.99816	0.064365	0.064365	2.78	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-2428924	IGF1R signaling cascade	32	35	1	1	1	1	1	1	1	1	1	8	34	4849	0.99827	0.062628	0.062628	2.86	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-2428928	IRS-related events triggered by IGF1R	31	34	1	1	1	1	1	1	1	1	1	8	33	4850	0.99836	0.060888	0.060888	2.94	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5654228	Phospholipase C-mediated cascade; FGFR4	9	10	1	1	1	1	1	1	1	1	1	8	9	4874	0.99987	0.018262	0.018262	10.0	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4		0.0	8.69275E-5	0.0	8.69275E-5	8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5654712	FRS-mediated FGFR4 signaling	14	15	1	1	1	1	1	1	1	1	1	8	14	4869	0.99969	0.027282	0.027282	6.67	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4		0.0	8.69275E-5			8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5654716	Downstream signaling of activated FGFR4	18	19	1	1	1	1	1	1	1	1	1	8	18	4865	0.99949	0.034445	0.034445	5.26	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4		0.0	8.69275E-5			8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5654719	SHC-mediated cascade:FGFR4	13	14	1	1	1	1	1	1	1	1	1	8	13	4870	0.99973	0.025484	0.025484	7.14	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4		0.0	8.69275E-5			8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5654720	PI-3K cascade:FGFR4	14	15	1	1	1	1	1	1	1	1	1	8	14	4869	0.99969	0.027282	0.027282	6.67	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4		0.0	8.69275E-5			8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5654733	Negative regulation of FGFR4 signaling	23	24	1	1	1	1	1	1	1	1	1	8	23	4860	0.99919	0.043332	0.043332	4.17	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5654743	Signaling by FGFR4	30	31	1	1	1	1	1	1	1	1	1	8	30	4853	0.99864	0.055652	0.055652	3.23	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5673001	RAF/MAP kinase cascade	153	157	1	1	1	1	1	1	1	1	1	8	156	4727	0.96823	0.25459	0.25459	0.64	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5683057	MAPK family signaling cascades	175	180	1	1	1	1	1	1	1	1	1	8	179	4704	0.95912	0.28658	0.28658	0.56	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-5684996	MAPK1/MAPK3 signaling	156	161	1	1	1	1	1	1	1	1	1	8	160	4723	0.96671	0.26024	0.26024	0.62	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	63	67	2	1	1	2	1	1	2	1	1	8	66	4817	0.99375	0.11681	0.11681	1.49	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-74751	Insulin receptor signalling cascade	31	34	1	1	1	1	1	1	1	1	1	8	33	4850	0.99836	0.060888	0.060888	2.94	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-74752	Signaling by Insulin receptor	43	46	1	1	1	1	1	1	1	1	1	8	45	4838	0.99701	0.081578	0.081578	2.17	368245	fgf19	ENSDARG00000098663		8.69275E-5	8.69275E-5	8.69275E-5		8.69275E-5		5.18593E-5	5.18593E-5	5.18593E-5		5.18593E-5		1.79638E-4	1.79638E-4	1.79638E-4		1.79638E-4						8.69275E-5	5.18593E-5	1.79638E-4	1	0	1	368245	ENSDARG00000098663	8.69275E-5	8.69275E-5		5.18593E-5	5.18593E-5		1.79638E-4	1.79638E-4		8.69275E-5	5.18593E-5	1.79638E-4	0															0						Exp 4,1(1)	2.1081173419952393	2.1081173419952393	2.1081173419952393	2.1081173419952393	0.0	2.1081173419952393	8.69275E-5	8.69275E-5	5.18593E-5	5.18593E-5	1.79638E-4	1.79638E-4	UP	1.0	0.0	0.0	
R-DRE-141424	Amplification of signal from the kinetochores	60	61	3	1	0	3	1	1	3	0	0	9	61	4822	0.89313	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	60	61	3	1	0	3	1	1	3	0	0	9	61	4822	0.89313	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-194315	Signaling by Rho GTPases	377	394	5	2	0	5	2	2	5	0	0	9	394	4489	0.46937	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-195258	RHO GTPase Effectors	163	179	3	1	0	3	1	1	3	0	0	9	179	4704	0.71479	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2467813	Separation of Sister Chromatids	126	129	3	1	0	3	1	1	3	0	0	9	129	4754	0.78607	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2500257	Resolution of Sister Chromatid Cohesion	77	78	3	1	0	3	1	1	3	0	0	9	78	4805	0.86522	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2555396	Mitotic Metaphase and Anaphase	153	156	3	1	0	3	1	1	3	0	0	9	156	4727	0.74683	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5663220	RHO GTPases Activate Formins	78	79	3	1	0	3	1	1	3	0	0	9	79	4804	0.8636	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68877	Mitotic Prometaphase	118	119	4	1	0	4	1	1	4	0	0	9	119	4764	0.80106	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68882	Mitotic Anaphase	152	155	3	1	0	3	1	1	3	0	0	9	155	4728	0.74825	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68886	M Phase	234	252	5	2	0	5	2	2	5	0	0	9	252	4631	0.62103	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69618	Mitotic Spindle Checkpoint	74	75	3	1	0	3	1	1	3	0	0	9	75	4808	0.87009	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69620	Cell Cycle Checkpoints	173	187	4	2	1	3	2	1	4	0	0	9	187	4696	0.70393	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9648025	EML4 and NUDC in mitotic spindle formation	68	69	3	1	0	3	1	1	3	0	0	9	69	4814	0.8799	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9716542	Signaling by Rho GTPases, Miro GTPases and RHOBTB3	386	403	5	2	0	5	2	2	5	0	0	9	403	4480	0.46098	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	37	40	1	1	0	1	1	1	1	0	0	9	40	4843	0.92872	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-446203	Asparagine N-linked glycosylation	157	160	1	0	0	1	0	0	1	0	0	9	160	4723	0.74117	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9012999	RHO GTPase cycle	251	252	2	1	0	2	1	1	2	0	0	9	252	4631	0.62103	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693532	DNA Double-Strand Break Repair	79	90	1	1	1	0	1	0	1	0	0	9	90	4793	0.84598	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693538	Homology Directed Repair	63	74	1	1	1	0	1	0	1	0	0	9	74	4809	0.87171	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693567	HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	58	69	1	1	1	0	1	0	1	0	0	9	69	4814	0.8799	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69473	G2/M DNA damage checkpoint	47	57	1	1	1	0	1	0	1	0	0	9	57	4826	0.89981	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69481	G2/M Checkpoints	95	107	1	1	1	0	1	0	1	0	0	9	107	4776	0.81938	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73894	DNA Repair	165	177	2	1	1	1	1	0	2	0	0	9	177	4706	0.71753	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-71291	Metabolism of amino acids and derivatives	147	156	1	1	1	1	1	1	1	1	1	8	155	4728	0.9686	0.25317	0.25317	0.64	402826	amdhd1	ENSDARG00000007366		1.03994	1.03994	1.03994		1.03994		0.617213	0.617213	0.617213		0.617213		2.4619	2.4619	2.4619		2.4619						1.03994	0.617213	2.4619	0	1	0															1	402826	ENSDARG00000007366	1.03994	1.03994		0.617213	0.617213		2.4619	2.4619		1.03994	0.617213	2.4619	0						Exp 2,1(1)	1.631037950515747	1.631037950515747	1.631037950515747	1.631037950515747	0.0	1.631037950515747	1.03994	1.03994	0.617213	0.617213	2.4619	2.4619	DOWN	0.0	1.0	0.0	
R-DRE-556833	Metabolism of lipids	332	343	2	2	1	1	2	1	2	0	0	9	343	4540	0.51955	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8978868	Fatty acid metabolism	92	94	1	1	0	1	1	1	1	0	0	9	94	4789	0.83966	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2262752	Cellular responses to stress	302	336	1	0	0	1	0	0	1	0	0	9	336	4547	0.52679	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8953897	Cellular responses to stimuli	302	336	1	0	0	1	0	0	1	0	0	9	336	4547	0.52679	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013148	CDC42 GTPase cycle	85	85	1	1	0	1	1	1	1	0	0	9	85	4798	0.85395	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013149	RAC1 GTPase cycle	91	91	1	1	0	1	1	1	1	0	0	9	91	4792	0.8444	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013404	RAC2 GTPase cycle	39	39	1	1	0	1	1	1	1	0	0	9	39	4844	0.93044	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013423	RAC3 GTPase cycle	51	51	1	1	0	1	1	1	1	0	0	9	51	4832	0.90992	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983231	Factors involved in megakaryocyte development and platelet production	76	82	2	2	0	2	2	2	2	0	0	9	82	4801	0.85876	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-375280	Amine ligand-binding receptors	22	55	1	1	1	0	0	0	1	0	0	9	55	4828	0.90317	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6804756	Regulation of TP53 Activity through Phosphorylation	58	60	1	1	1	0	1	0	1	0	0	9	60	4823	0.8948	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-418555	G alpha (s) signalling events	62	102	2	1	1	2	1	1	2	1	1	8	101	4782	0.98591	0.17287	0.17287	0.98	503868	vipr1b	ENSDARG00000059058		1.49581	1.49581	1.49581		1.49581		0.783669	0.783669	0.783669		0.783669		5.27487	5.27487	5.27487		5.27487						1.49581	0.783669	5.27487	0	1	0															1	503868	ENSDARG00000059058	1.49581	1.49581		0.783669	0.783669		5.27487	5.27487		1.49581	0.783669	5.27487	0						Exp 2,1(1)	1.5919537544250488	1.5919537544250488	1.5919537544250488	1.5919537544250488	0.0	1.5919537544250488	1.49581	1.49581	0.783669	0.783669	5.27487	5.27487	DOWN	0.0	1.0	0.0	
R-DRE-73887	Death Receptor Signalling	74	78	1	0	0	1	0	0	1	0	0	9	78	4805	0.86522	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	9	10	1	1	0	1	1	1	1	0	0	9	10	4873	0.98174	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2142753	Arachidonic acid metabolism	29	30	1	1	0	1	1	1	1	0	0	9	30	4853	0.9461	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-382556	ABC-family proteins mediated transport	63	65	1	1	1	1	1	1	1	1	1	8	64	4819	0.99411	0.11351	0.11351	1.54	566555	abcc6a	ENSDARG00000016750		1.80485	1.80485	1.80485		1.80485		1.04797	1.04797	1.04797		1.04797		6.3778	6.3778	6.3778		6.3778						1.80485	1.04797	6.3778	1	0	1	566555	ENSDARG00000016750	1.80485	1.80485		1.04797	1.04797		6.3778	6.3778		1.80485	1.04797	6.3778	0															0						Linear,1(1)	1.5030701160430908	1.5030701160430908	1.5030701160430908	1.5030701160430908	0.0	1.5030701160430908	1.80485	1.80485	1.04797	1.04797	6.3778	6.3778	UP	1.0	0.0	0.0	
R-DRE-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	99	100	2	2	0	2	2	2	2	0	0	9	100	4783	0.83025	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8856828	Clathrin-mediated endocytosis	83	84	1	1	1	0	0	0	1	0	0	9	84	4799	0.85555	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-157579	Telomere Maintenance	35	45	1	0	0	1	0	0	1	0	0	9	45	4838	0.92013	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-171319	Telomere Extension By Telomerase	12	13	1	0	0	1	0	0	1	0	0	9	13	4870	0.97632	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-180786	Extension of Telomeres	27	28	1	0	0	1	0	0	1	0	0	9	28	4855	0.94961	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73886	Chromosome Maintenance	52	63	2	0	0	2	0	0	2	0	0	9	63	4820	0.88981	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-373080	Class B/2 (Secretin family receptors)	37	38	2	1	1	2	1	1	2	1	1	8	37	4846	0.99796	0.067831	0.067831	2.63	503868	vipr1b	ENSDARG00000059058		1.49581	1.49581	1.49581		1.49581		0.783669	0.783669	0.783669		0.783669		5.27487	5.27487	5.27487		5.27487						1.49581	0.783669	5.27487	0	1	0															1	503868	ENSDARG00000059058	1.49581	1.49581		0.783669	0.783669		5.27487	5.27487		1.49581	0.783669	5.27487	0						Exp 2,1(1)	1.5919537544250488	1.5919537544250488	1.5919537544250488	1.5919537544250488	0.0	1.5919537544250488	1.49581	1.49581	0.783669	0.783669	5.27487	5.27487	DOWN	0.0	1.0	0.0	
R-DRE-8980692	RHOA GTPase cycle	77	77	2	1	0	2	1	1	2	0	0	9	77	4806	0.86684	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013106	RHOC GTPase cycle	39	39	1	1	0	1	1	1	1	0	0	9	39	4844	0.93044	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9013405	RHOD GTPase cycle	30	30	1	1	0	1	1	1	1	0	0	9	30	4853	0.9461	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6791312	TP53 Regulates Transcription of Cell Cycle Genes	26	27	1	1	0	1	1	1	1	0	0	9	27	4856	0.95137	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-70921	Histidine catabolism	2	2	1	1	1	1	1	1	1	1	1	8	1	4882	1.0	0.0036765	0.0036765	50.0	402826	amdhd1	ENSDARG00000007366		1.03994	1.03994	1.03994		1.03994		0.617213	0.617213	0.617213		0.617213		2.4619	2.4619	2.4619		2.4619		0.0	1.03994	0.0	1.03994	1.03994	0.617213	2.4619	0	1	0															1	402826	ENSDARG00000007366	1.03994	1.03994		0.617213	0.617213		2.4619	2.4619		1.03994	0.617213	2.4619	0						Exp 2,1(1)	1.631037950515747	1.631037950515747	1.631037950515747	1.631037950515747	0.0	1.631037950515747	1.03994	1.03994	0.617213	0.617213	2.4619	2.4619	DOWN	0.0	1.0	0.0	
R-DRE-2559583	Cellular Senescence	84	112	1	0	0	1	0	0	1	0	0	9	112	4771	0.8117	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2559586	DNA Damage/Telomere Stress Induced Senescence	26	48	1	0	0	1	0	0	1	0	0	9	48	4835	0.91501	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-389359	CD28 dependent Vav1 pathway	10	10	1	0	0	1	0	0	1	0	0	9	10	4873	0.98174	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	41	43	1	0	0	1	0	0	1	0	0	9	43	4840	0.92356	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-446219	Synthesis of substrates in N-glycan biosythesis	36	37	1	0	0	1	0	0	1	0	0	9	37	4846	0.9339	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2168880	Scavenging of heme from plasma	11	15	1	1	1	1	1	1	1	1	1	8	14	4869	0.99969	0.027282	0.027282	6.67	327588	hpxa	ENSDARG00000012609		1.22493	1.22493	1.22493		1.22493		0.795138	0.795138	0.795138		0.795138		2.61243	2.61243	2.61243		2.6124299999999994		0.0	1.22493			1.22493	0.795138	2.61243	1	0	1	327588	ENSDARG00000012609	1.22493	1.22493		0.795138	0.795138		2.61243	2.61243		1.22493	0.795138	2.61243	0															0						Linear,1(1)	2.2946460247039795	2.2946460247039795	2.2946460247039795	2.2946460247039795	0.0	2.2946460247039795	1.22493	1.22493	0.795138	0.795138	2.61243	2.61243	UP	1.0	0.0	0.0	
R-DRE-2173782	Binding and Uptake of Ligands by Scavenger Receptors	19	23	1	1	1	1	1	1	1	1	1	8	22	4861	0.99925	0.04156	0.04156	4.35	327588	hpxa	ENSDARG00000012609		1.22493	1.22493	1.22493		1.22493		0.795138	0.795138	0.795138		0.795138		2.61243	2.61243	2.61243		2.6124299999999994						1.22493	0.795138	2.61243	1	0	1	327588	ENSDARG00000012609	1.22493	1.22493		0.795138	0.795138		2.61243	2.61243		1.22493	0.795138	2.61243	0															0						Linear,1(1)	2.2946460247039795	2.2946460247039795	2.2946460247039795	2.2946460247039795	0.0	2.2946460247039795	1.22493	1.22493	0.795138	0.795138	2.61243	2.61243	UP	1.0	0.0	0.0	
R-DRE-383280	Nuclear Receptor transcription pathway	34	37	1	1	0	1	1	1	1	0	0	9	37	4846	0.9339	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8856825	Cargo recognition for clathrin-mediated endocytosis	57	58	1	1	1	0	0	0	1	0	0	9	58	4825	0.89814	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193704	p75 NTR receptor-mediated signalling	44	47	1	0	0	1	0	0	1	0	0	9	47	4836	0.91672	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-416482	G alpha (12/13) signalling events	45	45	1	0	0	1	0	0	1	0	0	9	45	4838	0.92013	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6811434	COPI-dependent Golgi-to-ER retrograde traffic	57	57	2	2	0	2	2	2	2	0	0	9	57	4826	0.89981	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8856688	Golgi-to-ER retrograde transport	64	64	2	2	0	2	2	2	2	0	0	9	64	4819	0.88815	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-983189	Kinesins	31	31	2	2	0	2	2	2	2	0	0	9	31	4852	0.94435	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73884	Base Excision Repair	29	38	1	0	0	1	0	0	1	0	0	9	38	4845	0.93217	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73929	Base-Excision Repair, AP Site Formation	15	24	1	0	0	1	0	0	1	0	0	9	24	4859	0.95667	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9018678	Biosynthesis of specialized proresolving mediators (SPMs)	17	17	1	1	0	1	1	1	1	0	0	9	17	4866	0.96913	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1660661	Sphingolipid de novo biosynthesis	27	27	1	1	1	0	1	0	1	0	0	9	27	4856	0.95137	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-428157	Sphingolipid metabolism	49	50	1	1	1	0	1	0	1	0	0	9	50	4833	0.91162	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2299718	Condensation of Prophase Chromosomes	21	36	1	0	0	1	0	0	1	0	0	9	36	4847	0.93563	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68875	Mitotic Prophase	49	64	1	0	0	1	0	0	1	0	0	9	64	4819	0.88815	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-110330	Recognition and association of DNA glycosylase with site containing an affected purine	11	20	1	0	0	1	0	0	1	0	0	9	20	4863	0.96377	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-110331	Cleavage of the damaged purine	12	21	1	0	0	1	0	0	1	0	0	9	21	4862	0.96199	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-606279	Deposition of new CENPA-containing nucleosomes at the centromere	23	33	1	0	0	1	0	0	1	0	0	9	33	4850	0.94085	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-73927	Depurination	12	21	1	0	0	1	0	0	1	0	0	9	21	4862	0.96199	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-774815	Nucleosome assembly	23	33	1	0	0	1	0	0	1	0	0	9	33	4850	0.94085	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-9670095	Inhibition of DNA recombination at telomere	12	21	1	0	0	1	0	0	1	0	0	9	21	4862	0.96199	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-174411	Polymerase switching on the C-strand of the telomere	15	15	1	0	0	1	0	0	1	0	0	9	15	4868	0.97272	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-174417	Telomere C-strand (Lagging Strand) Synthesis	19	19	1	0	0	1	0	0	1	0	0	9	19	4864	0.96556	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-174430	Telomere C-strand synthesis initiation	10	10	1	0	0	1	0	0	1	0	0	9	10	4873	0.98174	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-171306	Packaging Of Telomere Ends	10	19	1	0	0	1	0	0	1	0	0	9	19	4864	0.96556	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-390648	Muscarinic acetylcholine receptors	3	3	1	1	1	0	0	0	1	0	0	9	3	4880	0.99449	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-193648	NRAGE signals death through JNK	25	25	1	0	0	1	0	0	1	0	0	9	25	4858	0.9549	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-204998	Cell death signalling via NRAGE, NRIF and NADE	33	34	1	0	0	1	0	0	1	0	0	9	34	4849	0.93911	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	6	7	1	1	0	1	1	1	1	0	0	9	7	4876	0.98718	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69615	G1/S DNA Damage Checkpoints	43	46	1	1	1	0	1	0	1	0	0	9	46	4837	0.91842	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-373753	Nephrin family interactions	6	6	1	1	0	1	1	1	1	0	0	9	6	4877	0.98901	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-1433557	Signaling by SCF-KIT	23	23	1	1	1	0	1	0	1	0	0	9	23	4860	0.95844	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	23	23	1	1	1	1	1	1	1	1	1	8	22	4861	0.99925	0.04156	0.04156	4.35	553692	dph3	ENSDARG00000043360		1.17298	1.17298	1.17298		1.1729799999999997		0.769009	0.769009	0.769009		0.7690090000000002		2.42018	2.42018	2.42018		2.42018						1.17298	0.769009	2.42018	1	0	1	553692	ENSDARG00000043360	1.17298	1.17298		0.769009	0.769009		2.42018	2.42018		1.17298	0.769009	2.42018	0															0						Linear,1(1)	1.7452269792556763	1.7452269792556763	1.7452269792556763	1.7452269792556763	0.0	1.7452269792556763	1.17298	1.17298	0.769009	0.769009	2.42018	2.42018	UP	1.0	0.0	0.0	
R-DRE-176187	Activation of ATR in response to replication stress	21	22	1	1	1	0	1	0	1	0	0	9	22	4861	0.96021	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5685942	HDR through Homologous Recombination (HRR)	36	37	1	1	1	0	1	0	1	0	0	9	37	4846	0.9339	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693579	Homologous DNA Pairing and Strand Exchange	23	24	1	1	1	0	1	0	1	0	0	9	24	4859	0.95667	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	23	24	1	1	1	0	1	0	1	0	0	9	24	4859	0.95667	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	36	38	1	1	1	0	1	0	1	0	0	9	38	4845	0.93217	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69610	p53-Independent DNA Damage Response	36	38	1	1	1	0	1	0	1	0	0	9	38	4845	0.93217	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-69613	p53-Independent G1/S DNA damage checkpoint	36	38	1	1	1	0	1	0	1	0	0	9	38	4845	0.93217	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-8953750	Transcriptional Regulation by E2F6	19	19	1	1	1	0	1	0	1	0	0	9	19	4864	0.96556	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2514853	Condensation of Prometaphase Chromosomes	7	7	1	0	0	1	0	0	1	0	0	9	7	4876	0.98718	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2142688	Synthesis of 5-eicosatetraenoic acids	5	5	1	1	0	1	1	1	1	0	0	9	5	4878	0.99083	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-2142700	Synthesis of Lipoxins (LX)	4	4	1	1	0	1	1	1	1	0	0	9	4	4879	0.99266	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-68884	Mitotic Telophase/Cytokinesis	9	9	1	1	0	1	1	1	1	0	0	9	9	4874	0.98355	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-420092	Glucagon-type ligand receptors	23	23	1	1	1	1	1	1	1	1	1	8	22	4861	0.99925	0.04156	0.04156	4.35	503868	vipr1b	ENSDARG00000059058		1.49581	1.49581	1.49581		1.49581		0.783669	0.783669	0.783669		0.783669		5.27487	5.27487	5.27487		5.27487						1.49581	0.783669	5.27487	0	1	0															1	503868	ENSDARG00000059058	1.49581	1.49581		0.783669	0.783669		5.27487	5.27487		1.49581	0.783669	5.27487	0						Exp 2,1(1)	1.5919537544250488	1.5919537544250488	1.5919537544250488	1.5919537544250488	0.0	1.5919537544250488	1.49581	1.49581	0.783669	0.783669	5.27487	5.27487	DOWN	0.0	1.0	0.0	
R-DRE-174414	Processive synthesis on the C-strand of the telomere	10	10	1	0	0	1	0	0	1	0	0	9	10	4873	0.98174	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-174437	Removal of the Flap Intermediate from the C-strand	9	9	1	0	0	1	0	0	1	0	0	9	9	4874	0.98355	1.0	1.0	0.0																														0	0	0															0															0																							
R-DRE-5358493	Synthesis of diphthamide-EEF2	6	6	1	1	1	1	1	1	1	1	1	8	5	4878	0.99996	0.010993	0.010993	16.67	553692	dph3	ENSDARG00000043360		1.17298	1.17298	1.17298		1.1729799999999997		0.769009	0.769009	0.769009		0.7690090000000002		2.42018	2.42018	2.42018		2.42018		0.0	1.17298	0.0	1.17298	1.17298	0.769009	2.42018	1	0	1	553692	ENSDARG00000043360	1.17298	1.17298		0.769009	0.769009		2.42018	2.42018		1.17298	0.769009	2.42018	0															0						Linear,1(1)	1.7452269792556763	1.7452269792556763	1.7452269792556763	1.7452269792556763	0.0	1.7452269792556763	1.17298	1.17298	0.769009	0.769009	2.42018	2.42018	UP	1.0	0.0	0.0	
R-DRE-419408	Lysosphingolipid and LPA receptors	8	9	1	1	1	1	1	1	1	1	1	8	8	4875	0.99989	0.01645	0.01645	11.11	322473	lpar5a	ENSDARG00000010384		1.2345	1.2345	1.2345		1.2345		0.799884	0.799884	0.799884		0.799884		2.6494	2.6494	2.6494		2.6494		0.0	1.2345	0.0	1.2345	1.2345	0.799884	2.6494	0	1	0															1	322473	ENSDARG00000010384	1.2345	1.2345		0.799884	0.799884		2.6494	2.6494		1.2345	0.799884	2.6494	0						Linear,1(1)	1.8201133012771606	1.8201133012771606	1.8201133012771606	1.8201133012771606	0.0	1.8201133012771606	1.2345	1.2345	0.799884	0.799884	2.6494	2.6494	DOWN	0.0	1.0	0.0	
R-DRE-480985	Synthesis of dolichyl-phosphate-glucose	1	1	1	0	0	1	0	0	1	0	0	9	1	4882	0.99816	1.0	1.0	0.0																														0	0	0															0															0																							
